CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.14B
1-Year Return
47.7%
This Quarter Return
+9.46%
1 Year Return
+47.7%
3 Year Return
+76.82%
5 Year Return
+185.43%
10 Year Return
+401.35%
AUM
$2.19B
AUM Growth
-$367M
(-14%)
Cap. Flow
-$451M
Cap. Flow
% of AUM
-20.6%
Top 10 Holdings %
Top 10 Hldgs %
59.38%
Holding
671
New
207
Increased
118
Reduced
162
Closed
160
Top Buys
| 1 |
Tesla
TSLA
|
+$307M |
| 2 |
Amazon
AMZN
|
+$231M |
| 3 |
Boston Scientific
BSX
|
+$58.7M |
| 4 |
PayPal
PYPL
|
+$50M |
| 5 |
Meta Platforms (Facebook)
META
|
+$32.7M |
Top Sells
| 1 |
Citigroup
C
|
+$244M |
| 2 |
Micron Technology
MU
|
+$171M |
| 3 |
Intel
INTC
|
+$163M |
| 4 |
Microsoft
MSFT
|
+$122M |
| 5 |
Apple
AAPL
|
+$117M |
Sector Composition
| 1 | Consumer Discretionary | 39.22% |
| 2 | Technology | 23.66% |
| 3 | Healthcare | 7.32% |
| 4 | Financials | 7.08% |
| 5 | Energy | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Atour Lifestyle Holdings
ATAT
$5.44B
| $618K | 0.02% |
+23,832
| New | +$618K |
|
327
Regeneron Pharmaceuticals
REGN
$58.9B
| $618K | 0.02% |
588
-562
| -49% | -$591K |
|
328
CVS Health
CVS
$93.3B
| $617K | 0.02% |
+9,811
| New | +$617K |
|
329
NETSCOUT
NTCT
$1.8B
| $615K | 0.02% |
28,266
-5,565
| -16% | -$121K |
|
330
Smith & Wesson
SWBI
$386M
| $613K | 0.02% |
47,256
+28,289
| +149% | +$367K |
|
331
Mohawk Industries
MHK
$8.39B
| $608K | 0.02% |
+3,783
| New | +$608K |
|
332
Expedia Group
EXPE
$26.5B
| $605K | 0.02% |
+4,088
| New | +$605K |
|
333
F5
FFIV
$18.7B
| $604K | 0.02% |
+2,745
| New | +$604K |
|
334
Okta
OKTA
$15.9B
| $604K | 0.02% |
+8,125
| New | +$604K |
|
335
Insmed
INSM
$30.5B
| $604K | 0.02% |
+8,269
| New | +$604K |
|
336
Rhythm Pharmaceuticals
RYTM
$6.69B
| $602K | 0.02% |
+11,491
| New | +$602K |
|
|
MTTR
337
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $599K | 0.02% |
+133,189
| New | +$599K |
|
338
CRA International
CRAI
$1.26B
| $597K | 0.02% |
+3,405
| New | +$597K |
|
339
Fate Therapeutics
FATE
$115M
| $588K | 0.02% |
167,957
-4,906
| -3% | -$17.2K |
|
340
Nu Skin
NUS
$566M
| $580K | 0.02% |
78,736
+29,894
| +61% | +$220K |
|
341
Eagle Bancorp
EGBN
$593M
| $579K | 0.02% |
25,622
-48,369
| -65% | -$1.09M |
|
342
Zymeworks
ZYME
$1.16B
| $575K | 0.02% |
+45,810
| New | +$575K |
|
343
Capitol Federal Financial
CFFN
$840M
| $565K | 0.02% |
96,693
-47,042
| -33% | -$275K |
|
344
Sonic Automotive
SAH
$2.78B
| $554K | 0.02% |
+9,473
| New | +$554K |
|
345
Axon Enterprise
AXON
$58.1B
| $548K | 0.02% |
+1,371
| New | +$548K |
|
346
CarGurus
CARG
$3.53B
| $547K | 0.02% |
18,228
-789
| -4% | -$23.7K |
|
347
BrightView Holdings
BV
$1.3B
| $547K | 0.02% |
34,776
-17,670
| -34% | -$278K |
|
348
Powell Industries
POWL
$3.37B
| $538K | 0.02% |
2,424
-5,061
| -68% | -$1.12M |
|
349
Hillenbrand
HI
$1.76B
| $538K | 0.02% |
+19,354
| New | +$538K |
|
350
Ambac
AMBC
$415M
| $536K | 0.02% |
47,858
+22,581
| +89% | +$253K |
|